Journal Article

Characterization of a 1200-kb Genomic Segment of Chromosome 3p22-p21.3

Yataro Daigo, Minoru Isomura, Tadashi Nishiwaki, Mayumi Tamari, Shinji Ishikawa, Mikio Kai, Yasushi Murata, Kumiko Takeuchi, Yuka Yamane, Rie Hayashi, Maiko Minami, Masayuki A. Fujino, Yoshiaki Hojo, Ikuo Uchiyama, Toshihisa Takagi and Yusuke Nakamura

in DNA Research

Published on behalf of Kazusa DNA Research Institute

Volume 6, issue 1, pages 37-44
Published in print January 1999 | ISSN: 1340-2838
Published online January 1999 | e-ISSN: 1756-1663 | DOI: http://dx.doi.org/10.1093/dnares/6.1.37

Show Summary Details

Preview

We previously determined the nucleotide sequence and characterized the 685-kb proximal half of CEPH YAC936c1, which corresponds to a portion of human chromosome 3p21.3. In the study reported here, we characterized the remaining 515-kb of this YAC clone corresponding to the telomeric half of its human insert. The newly sequenced region contained a total of ten genes including six reported previously: phospholipase C delta 1 (PLCD1), human activin receptor type IIB (hActR-IIB), organic cation transporter-like 1 (OCTL1), organic cation transporter-like 2 (OCTL2), oxidative stress response 1 (OSR1), and human xylulokinase-like protein (XYLB). The remaining four genes present in the telomeric region included two known genes, MyD88 and ACAA, and two novel genes. One (designated ENGL) of the novel sequences was found to encode an amino-acid sequence homologous to the family of DNA/RNA endonucleases, especially endonuclease G. The other gene F56 revealed no significant homology to any known genes. These results disclosed complete physical and transcriptional maps of the 1200-kb region of 3p present in YAC 936c1.

Keywords: large-scale DNA sequencing; tumor suppressor genes; homozygously deleted region; physical and transcriptional maps; human chromosome 3p22-p21.3

Journal Article.  0 words. 

Subjects: Genetics and Genomics

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.